Anti-Tat Immunity in HIV-1 Infection: Effects of Naturally Occurring and Vaccine-Induced Antibodies Against Tat on the Course of the Disease

Total Page:16

File Type:pdf, Size:1020Kb

Anti-Tat Immunity in HIV-1 Infection: Effects of Naturally Occurring and Vaccine-Induced Antibodies Against Tat on the Course of the Disease Review Anti-Tat Immunity in HIV-1 Infection: Effects of Naturally Occurring and Vaccine-Induced Antibodies Against Tat on the Course of the Disease Aurelio Cafaro , Antonella Tripiciano, Orietta Picconi, Cecilia Sgadari , Sonia Moretti, Stefano Buttò, Paolo Monini and Barbara Ensoli * National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome 00161, Italy * Correspondence: [email protected]; Tel.: +39-06-4990-3209; Fax: +39-06-4990-3002 Received: 16 July 2019; Accepted: 15 August 2019; Published: 26 August 2019 Abstract: HIV-1 Tat is an essential protein in the virus life cycle, which is required for virus gene expression and replication. Most Tat that is produced during infection is released extracellularly and it plays a key role in HIV pathogenesis, including residual disease upon combination antiretroviral therapy (cART). Here, we review epidemiological and experimental evidence showing that antibodies against HIV-1 Tat, infrequently occurring in natural infection, play a protective role against disease progression, and that vaccine targeting Tat can intensify cART. In fact, Tat vaccination of subjects on suppressive cART in Italy and South Africa promoted immune restoration, including CD4+ T-cell increase in low immunological responders, and a reduction of proviral DNA even after six years of cART, when both CD4+ T-cell gain and DNA decay have reached a plateau. Of note, DNA decay was predicted by the neutralization of Tat-mediated entry of Env into dendritic cells by anti-Tat antibodies, which were cross-clade binding and neutralizing. Anti-Tat cellular immunity also contributed to the DNA decay. Based on these data, we propose the Tat therapeutic vaccine as a pathogenesis-driven intervention that effectively intensifies cART and it may lead to a functional cure, providing new perspectives and opportunities also for prevention and virus eradication strategies. Keywords: HIV-1 Tat; anti-Tat antibodies; natural vs. vaccine-induced antibody response; crossclade antibodies; HIV-1 vaccine development; HIV-1 Tat therapeutic vaccine; HIV reservoir; cART intensification; functional cure; perspective for clinical implications 1. Introduction An HIV vaccine is still the most valuable and cost-effective intervention to end the HIV/AIDS pandemic [1]. We focused on the HIV-1 Tat (TransActivator of Transcription) protein as an optimal pathogenetic vaccine target because of the inherent difficulties in developing vaccine strategies capable of inducing cross clade broadly neutralizing antibodies (bNAbs) against HIV-1 Env [2]. This strategy stems from the results of epidemiological and basic research studies on the role of Tat and anti-Tat immunity in the course of HIV infection. Here, we briefly review epidemiological and experimental evidence showing the role of Tat in the virus life cycle, with particular emphasis on extracellular Tat and on its effects on both the virus and the immune system. Conversely, we examine and discuss data on the protective effect of anti-Tat antibodies (Abs), naturally occurring or vaccine-induced, on the course of the disease including in suppressive cART. Further, we will discuss evidence on the role of anti-Tat Abs in blocking the formation of the Tat/Env complex that allows for Tat-mediated HIV entry through the RGD (arginyl-glycyl-aspartic acid tripeptide) binding integrins α5β1, αvβ3, and αvβ5, and it enhances the infection of cells expressing these integrins, such as dendritic cells (DCs). This is a novel path of virus entry and cell infection, likely Vaccines 2019, 7, 99; doi:10.3390/vaccines7030099 www.mdpi.com/journal/vaccines Vaccines 2019, 7, 99 2 of 26 increasing HIV acquisition, as indicated by results in monkeys’ studies, and most likely contributes to Vaccinesreservoir 2019, 7, generationx and maintenance. Finally, we examine the effects of anti-Tat Abs in accelerating2 of 26 the decay of the CD4+ T-cell HIV reservoir under long-term cART. Taken together, the results from the acquisition,studies described as indicated here suggestby results that in targeting monkeys’ HIV-1 studies, Tat, a veryand earlymost HIVlikely protein, contributes may represent to reservoir a generationvaluable and strategy maintenance. to intensify Finally, cART we to achieve examine HIV the functional effects of cureanti-Tat or eradication. Abs in accelerating Similarly, the a vaccine decay of the targetingCD4+ T-cell the TatHIV/Env reservoir complex under may represent long-term a novelcART strategy. Taken totogether, prevent the HIV results acquisition, from asthe will studies be describeddiscussed here below. suggest that targeting HIV-1 Tat, a very early HIV protein, may represent a valuable strategy to intensify cART to achieve HIV functional cure or eradication. Similarly, a vaccine targeting the Tat/Env2. Role complex of Tat inmay the represent Virus Life a novel Cycle strategy to prevent HIV acquisition, as will be discussed below. Tat is generated in two forms through alternative splicing. The first form is encoded by the 2. Role of Tat in the Virus Life Cycle multiply spliced two-exon transcript and it varies in length between 86 and 101 amino acids (aa), dependingTat is generated on the in viral two isolate. forms through The other alternative is encoded sp bylicing. a singly The first spliced form one-exon is encoded transcript by the andmultiply it splicedis 72 two-exon aa long. transcript Both Tat variantsand it varies transactivate in length thebetween LTR e86ffi ciently,and 101 butamino the acids two-exon (aa), depending Tat appears on to the viralexert isolate. additional The other effects is onencoded the infected by a singly cell, which spliced aff ectone-exon cytoskeleton transcript structure and it and is function72 aa long. [3], Both delay Tat variantsFas-mediated transactivate apoptosis the LTR [4], efficiently, and reduce but the the triggering two-exon of Tat innate appears and to adaptive exert additional immune effects responses, on the infectedsuch ascell, the which downregulation affect cytoskel of interferon-stimulatedeton structure and function genes and[3], delay MHC Fas-mediated class-I and II moleculesapoptosis gene[4], and reduceexpression the triggering in antigen of innate presenting and adaptive cells [5 –immune7]. Although responses, both such the one- as the and downregulation the two- exons of forms interferon- of stimulatedTat are producedgenes and and MHC functional, class-I theand latter II molecules is the form gene prevalently expression found in antigenin vivo (101presenting aa) and cellsin vitro [5–7]. Although(86 aa) both [8]. As the shown one- and in Figure the two-1, Tat exons contains forms six of domains: Tat are produced a proline-rich and functional, acidic N-terminus the latter (aa is 1–21),the form prevalentlya cysteine-rich found regionin vivo (aa(101 22–37), aa) and a hydrophobicin vitro (86 aa) core [8]. region As shown (aa 38–48), in Figure an arginine-rich1, Tat contains basic six domains: domain a proline-rich(aa 49–57), acidic a glutamin-rich N-terminus region (aa 1–21), (aa 60–76), a cysteine and-rich a C-terminal region (aa domain 22–37), containing a hydrophobic the RGD core sequence, region (aa 38–48),as recognized an arginine-rich by RGD-binding basic domain integrins. (aa 49–57), Of note, a glutamin-rich Tat is largely region unstructured (aa 60–76), and veryand a flexible, C-terminal a domainproperty containing that permits the RGD interactions sequence, with as recognized numerous partners,by RGD-binding as reported integrins. [8–12]. Of Unless note, Tat diff erentlyis largely unstructuredstated, thereafter and very the flexible, terms Tata property refers to that the two-exonpermits interactions Tat, particularly with numerous to the shortest partners, form as of reported 86 aa [8–12].in length. Unless differently stated, thereafter the terms Tat refers to the two-exon Tat, particularly to the shortest form of 86 aa in length. Figure 1. Functional domains of HIV-1 Tat (HXB2). Amino acid numbering according to the IIIB/Lai Figure 1. Functional domains of HIV-1 Tat (HXB2). Amino acid numbering according to the IIIB/Lai sequence. Tat can be divided into six domains: a proline-rich acidic N-terminus (aa 1–21), a cysteine-rich sequence. Tat can be divided into six domains: a proline-rich acidic N-terminus (aa 1–21), a cysteine-rich region (aa 22–37), a hydrophobic core region (aa 38–48), an arginine-rich basic domain (aa 49–57), a region (aa 22–37), a hydrophobic core region (aa 38–48), an arginine-rich basic domain (aa 49–57), a glutamin-rich region (aa 60–76) and a C-terminal domain containing the RGD sequence, recognized by glutamin-rich region (aa 60–76) and a C-terminal domain containing the RGD sequence, recognized by RGD-binding integrins. Shown is the 86 aa long form of Tat, commonly found in cell lines and used RGD-binding integrins. Shown is the 86 aa long form of Tat, commonly found in cell lines and used experimentally. However, in field isolates the 101 aa long form of Tat is mostly found [8]. experimentally. However, in field isolates the 101 aa long form of Tat is mostly found [8]. Although prominently known for its role in promoting transcription elongation, Tat participates Although prominently known for its role in promoting transcription elongation, Tat participates and and regulates several aspects of the HIV gene transcription program (Table1), both in the acute phase regulates several aspects of the HIV gene transcription program (Table 1), both in the acute phase of of infection and reactivation, irrespective of cART [13–17].
Recommended publications
  • Progressive Multifocal Leukoencephalopathy and the Spectrum of JC Virus-​Related Disease
    REVIEWS Progressive multifocal leukoencephalopathy and the spectrum of JC virus- related disease Irene Cortese 1 ✉ , Daniel S. Reich 2 and Avindra Nath3 Abstract | Progressive multifocal leukoencephalopathy (PML) is a devastating CNS infection caused by JC virus (JCV), a polyomavirus that commonly establishes persistent, asymptomatic infection in the general population. Emerging evidence that PML can be ameliorated with novel immunotherapeutic approaches calls for reassessment of PML pathophysiology and clinical course. PML results from JCV reactivation in the setting of impaired cellular immunity, and no antiviral therapies are available, so survival depends on reversal of the underlying immunosuppression. Antiretroviral therapies greatly reduce the risk of HIV-related PML, but many modern treatments for cancers, organ transplantation and chronic inflammatory disease cause immunosuppression that can be difficult to reverse. These treatments — most notably natalizumab for multiple sclerosis — have led to a surge of iatrogenic PML. The spectrum of presentations of JCV- related disease has evolved over time and may challenge current diagnostic criteria. Immunotherapeutic interventions, such as use of checkpoint inhibitors and adoptive T cell transfer, have shown promise but caution is needed in the management of immune reconstitution inflammatory syndrome, an exuberant immune response that can contribute to morbidity and death. Many people who survive PML are left with neurological sequelae and some with persistent, low-level viral replication in the CNS. As the number of people who survive PML increases, this lack of viral clearance could create challenges in the subsequent management of some underlying diseases. Progressive multifocal leukoencephalopathy (PML) is for multiple sclerosis. Taken together, HIV, lymphopro- a rare, debilitating and often fatal disease of the CNS liferative disease and multiple sclerosis account for the caused by JC virus (JCV).
    [Show full text]
  • Investigation of Proton Conductance in the Matrix 2 Protein of the Influenza Virus by Solution NMR Spectroscopy © Daniel Turman
    Investigation of proton conductance in the matrix 2 protein of the influenza virus by solution NMR spectroscopy © Daniel Turman Emmanuel College Class 0[2012 Abstract The Influenza Matrix 2 (M2) protein is a homo-tetrameric integral membrane protein that forms a proton selective transmembrane channell Its recognized function is to equilibrate pH across the viral envelope following endocytosis and across the trans-golgi membrane during viral maturation2 Its function is vital for viral infection and proliferation but the mechanism and selectivity of proton conductance is not well understood. Mutagenesis studies have identified histidine 37 as the pH sensing element and tryptophan 41 as the gating selectivity filter3 This study uses solution nuclear magnetic resonance spectroscopy and an M2 transmembrane protein construct to elucidate key interactions between the aromatic residues believed to confer proton selectivity and pH dependent conduction of M2 in the low pH open and high pH closed states. PH dependent 13 C_1 H HSQC-Trosy experiments were completed in the pH range of 8.0 - 4.0 and the 13 C, and 13 Co2 chemical shift perturbations of histidine 37 revealed multiple saturation points. The protonation states of histidine 37 suggest a shuttling mechanism for proton conduction. Introduction Influenza is a pathogenic virus that has reached pandemic status four times in the twentieth century. The latest pandemic occurred in 2009 from the influenza A HINI strain (figure 1t The World Health Organization (WHO) commented in July of 2009, "this outbreak is unstoppable." Following this event, significant research has been allocated to understand all aspects of the influenza virus in an effort to produce effective vaccines and medications to prevent and control another pandemic.
    [Show full text]
  • Lentivirus and Lentiviral Vectors Fact Sheet
    Lentivirus and Lentiviral Vectors Family: Retroviridae Genus: Lentivirus Enveloped Size: ~ 80 - 120 nm in diameter Genome: Two copies of positive-sense ssRNA inside a conical capsid Risk Group: 2 Lentivirus Characteristics Lentivirus (lente-, latin for “slow”) is a group of retroviruses characterized for a long incubation period. They are classified into five serogroups according to the vertebrate hosts they infect: bovine, equine, feline, ovine/caprine and primate. Some examples of lentiviruses are Human (HIV), Simian (SIV) and Feline (FIV) Immunodeficiency Viruses. Lentiviruses can deliver large amounts of genetic information into the DNA of host cells and can integrate in both dividing and non- dividing cells. The viral genome is passed onto daughter cells during division, making it one of the most efficient gene delivery vectors. Most lentiviral vectors are based on the Human Immunodeficiency Virus (HIV), which will be used as a model of lentiviral vector in this fact sheet. Structure of the HIV Virus The structure of HIV is different from that of other retroviruses. HIV is roughly spherical with a diameter of ~120 nm. HIV is composed of two copies of positive ssRNA that code for nine genes enclosed by a conical capsid containing 2,000 copies of the p24 protein. The ssRNA is tightly bound to nucleocapsid proteins, p7, and enzymes needed for the development of the virion: reverse transcriptase (RT), proteases (PR), ribonuclease and integrase (IN). A matrix composed of p17 surrounds the capsid ensuring the integrity of the virion. This, in turn, is surrounded by an envelope composed of two layers of phospholipids taken from the membrane of a human cell when a newly formed virus particle buds from the cell.
    [Show full text]
  • Respiratory Syncytial Virus and Coronaviruses
    Chapter 3 Structural and Functional Aspects of Viroporins in Human Respiratory Viruses: Respiratory Syncytial Virus and Coronaviruses Wahyu Surya, Montserrat Samsó and Jaume Torres Additional information is available at the end of the chapter http://dx.doi.org/10.5772/53957 1. Introduction Viroporins are an increasingly recognized class of small viral membrane proteins (~60-120 amino acids) which oligomerize to produce hydrophilic pores at the membranes of virus- infected cells [1]. The existence of ‘viroporins’ was proposed more than 30 years ago after observing enhanced membrane permeability in infected cells [2]. These proteins form oligomers of defined size, and can act as proton or ion channels, and in general enhancing membrane permeability in the host [3]. Even though viroporins are not essential for the rep‐ lication of viruses, their absence results in attenuated or weakened viruses or changes in tropism (organ localization) and therefore diminished pathological effects [4, 5]. In addition to having one – sometimes two – α-helical transmembrane (TM) domain(s), viro‐ porins usually contain additional extramembrane regions that are able to make contacts with viral or host proteins. Indeed, the network of interactions of viroporins with other viral or cellular proteins is key to understand the regulation of viral protein trafficking through the vesicle system, viral morphogenesis and pathogenicity. In general, viroporins participate in the entry or release of viral particles into or out of cells, and membrane permeabilization may be a desirable functionality for the virus. Indeed, sev‐ eral viral proteins that are not viroporins are known to affect membrane permeabilization, e.g., A38L protein of vaccinia virus, a 33-kDa glycoprotein that allows Ca2+ influx and indu‐ ces necrosis in infected cells [6].
    [Show full text]
  • Vpr Mediates Immune Evasion and HIV-1 Spread by David R. Collins A
    Vpr mediates immune evasion and HIV-1 spread by David R. Collins A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Microbiology and Immunology) in the University of Michigan 2015 Doctoral Committee: Professor Kathleen L. Collins, Chair Professor David M. Markovitz Associate Professor Akira Ono Professor Alice Telesnitsky © David R. Collins ________________________________ All Rights Reserved 2015 Dedication In loving memory of Sullivan James and Aiko Rin ii Acknowledgements I am very grateful to my mentor, Dr. Kathleen L. Collins, for providing excellent scientific training and guidance and for directing very exciting and important research. I am in the debt of my fellow Collins laboratory members, present and former, for their daily support, encouragement and assistance. In particular, I am thankful to Dr. Michael Mashiba for pioneering our laboratory’s investigation of Vpr, which laid the framework for this dissertation, and for key contributions to Chapter II and Appendix. I am grateful to Jay Lubow and Dr. Zana Lukic for their collaboration and contributions to ongoing work related to this dissertation. I also thank the members of my thesis committee, Dr. Akira Ono, Dr. Alice Telesnitsky, and Dr. David Markovitz for their scientific and professional guidance. Finally, this work would not have been possible without the unwavering love and support of my family, especially my wife Kali and our wonderful feline companions Ayumi, Sully and Aiko, for whom I continue to endure life’s
    [Show full text]
  • The Expression and Distribution of Insertionally Polymorphic Endogenous Retroviruses in Canine Cancer Derived Cell Lines
    THE EXPRESSION AND DISTRIBUTION OF INSERTIONALLY POLYMORPHIC ENDOGENOUS RETROVIRUSES IN CANINE CANCER DERIVED CELL LINES. Abigail S. Jarosz A Thesis Submitted to the Graduate College of Bowling Green State University in partial fulfillment of the requirements for the degree of MASTER OF SCIENCE August 2018 Committee: Julia Halo-Wildschutte, Advisor Raymond Larsen Zhaohui Xu © 2018 Abigail S. Jarosz All Rights Reserved iii ABSTRACT Julia Halo-Wildschutte, Advisor To our knowledge there are no current infectious retroviruses found in canines or wild canids. It has been previously thought that the canine reference genome consists only of about 0.15% of sequence of obvious retroviral origin, present as endogenous retroviruses (ERVs) within contemporary canids. In recent analyses of the canine reference genome, a few copies of ERVs were identified with features characteristic of recent integration, for example the presence of some ORFs and near-identical LTRs. Members of this group are referred to as CfERV-Fc1(a) and have been identified to have sequence similarity to the mammalian ERV-Fc/W groups. We have recently discovered and characterized a number of non-reference Fc1 copies in dogs and wild canids, and identified unexpectedly high levels of polymorphism among members of this ERV group. Some of the proviruses we have identified even possess complete or nearly intact open reading frames, identical LTRs, and derived phylogenetic clustering among other CfERV-Fc1(a) members. Based on LTR sequence divergence under an applied dog neutral mutation rate, it is thought these infections occurred within as recently as the last ~0.48 million years. There have been previous, but unsubstantiated, reports of reverse transcriptase activity as well as gamma-type C particles in tumor tissues of canines diagnosed with lymphoma.
    [Show full text]
  • Influenza Virus M2 Protein Ion Channel Activity Helps to Maintain Pandemic 2009 H1N1 Virus Hemagglutinin Fusion Competence Durin
    Influenza Virus M2 Protein Ion Channel Activity Helps To Maintain Pandemic 2009 H1N1 Virus Hemagglutinin Fusion Competence during Transport to the Cell Surface Esmeralda Alvarado-Facundo,a,b Yamei Gao,a Rosa María Ribas-Aparicio,b Alicia Jiménez-Alberto,b Carol D. Weiss,a Wei Wanga Division of Viral Products, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USAa; Departamento de Microbiología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City, Mexicob ABSTRACT The influenza virus hemagglutinin (HA) envelope protein mediates virus entry by first binding to cell surface receptors and then fusing viral and endosomal membranes during endocytosis. Cleavage of the HA precursor (HA0) into a surface receptor-binding Downloaded from subunit (HA1) and a fusion-inducing transmembrane subunit (HA2) by host cell enzymes primes HA for fusion competence by repositioning the fusion peptide to the newly created N terminus of HA2. We previously reported that the influenza virus M2 protein enhances pandemic 2009 influenza A virus [(H1N1)pdm09] HA-pseudovirus infectivity, but the mechanism was unclear. In this study, using cell-cell fusion and HA-pseudovirus infectivity assays, we found that the ion channel function of M2 was re- quired for enhancement of HA fusion and HA-pseudovirus infectivity. The M2 activity was needed only during HA biosynthesis, and proteolysis experiments indicated that M2 proton channel activity helped to protect (H1N1)pdm09 HA from premature conformational changes as it traversed low-pH compartments during transport to the cell surface. While M2 has previously been shown to protect avian influenza virus HA proteins of the H5 and H7 subtypes that have polybasic cleavage motifs, this study demonstrates that M2 can protect HA proteins from human H1N1 strains that lack a polybasic cleavage motif.
    [Show full text]
  • (HERV-K) Viral Env RNA in Pancreatic Cancer Cells Decreases Cell
    Published OnlineFirst July 5, 2017; DOI: 10.1158/1078-0432.CCR-17-0001 Cancer Therapy: Preclinical Clinical Cancer Research Downregulation of Human Endogenous Retrovirus Type K (HERV-K) Viral env RNA in Pancreatic Cancer Cells Decreases Cell Proliferation and Tumor Growth Ming Li1, Laszlo Radvanyi2, Bingnan Yin3, Kiera Rycaj4, Jia Li1, Raghavender Chivukula1, Kevin Lin4, Yue Lu4, JianJun Shen4, David Z. Chang5, Donghui Li6, Gary L. Johanning1, and Feng Wang-Johanning1 Abstract Purpose: We investigated the role of the human endogenous lines were significantly reduced after HERV-K KD by shRNA retrovirus type K (HERV-K) envelope (env) gene in pancreatic targeting HERV-K env, and there was reduced metastasis to cancer. lung after treatment. RNA-Seq results revealed changes in gene Experimental Design: shRNA was employed to knockdown expression after HERV-K env KD, including RAS and TP53. (KD) the expression of HERV-K in pancreatic cancer cells. Furthermore, downregulation of HERV-K Env protein expres- Results: HERV-K env expression was detected in seven pan- sion by shRNA also resulted in decreased expression of RAS, creatic cancer cell lines and in 80% of pancreatic cancer patient p-ERK, p-RSK, and p-AKT in several pancreatic cancer cells biopsies, but not in two normal pancreatic cell lines or or tumors. uninvolved normal tissues. A new HERV-K splice variant was Conclusions: These results demonstrate that HERV-K influ- discovered in several pancreatic cancer cell lines. Reverse ences signal transduction via the RAS–ERK–RSK pathway in transcriptase activity and virus-like particles were observed in pancreatic cancer. Our data highlight the potentially important culture media supernatant obtained from Panc-1 and Panc-2 role of HERV-K in tumorigenesis and progression of pancreatic cells.
    [Show full text]
  • HIV-1 Env Gp41 Transmembrane Domain Dynamics Are Modulated by Lipid, Wa- Ter, and Ion Interactions
    bioRxiv preprint doi: https://doi.org/10.1101/292326; this version posted March 30, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. HIV-1 Env gp41 Transmembrane Domain Dynamics are Modulated by Lipid, Wa- ter, and Ion Interactions L.R. Hollingsworth IV, J.A. Lemkul, D.R. Bevan, and A.M. Brown Running Title: gp41 trimer dynamics in a lipid membrane Keywords: molecular dynamics simulations, protein-membrane interactions, HIV-1 gp41, envelope glycoprotein 1 bioRxiv preprint doi: https://doi.org/10.1101/292326; this version posted March 30, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Abstract The gp41 transmembrane domain (TMD) of the envelope glycoprotein (Env) of the human immunodeficiency virus (HIV) modulates the conformation of the viral enve- lope spike, the only druggable target on the surface of the virion. Understanding of TMD dynamics is needed to better probe and target Env with small molecule and antibody therapies. However, little is known about TMD dynamics due to difficulties in describing native membrane properties. Here, we performed atomistic molecular dynamics simula- tions of a trimeric, prefusion TMD in a model, asymmetric viral membrane that mimics the native viral envelope. We found that water and chloride ions permeated the mem- brane and interacted with the highly conserved arginine bundle, (R696)3, at the center of the membrane and influenced TMD stability by creating a network of hydrogen bonds and electrostatic interactions.
    [Show full text]
  • Genomewide Screening for Fusogenic Human Endogenous Retrovirus Envelopes Identifies Syncytin 2, a Gene Conserved on Primate Evolution
    Genomewide screening for fusogenic human endogenous retrovirus envelopes identifies syncytin 2, a gene conserved on primate evolution Sandra Blaise, Nathalie de Parseval, Laurence Be´ nit, and Thierry Heidmann* Unite´des Re´trovirus Endoge`nes et Ele´ments Re´troı¨desdes Eucaryotes Supe´rieurs, Unite´Mixte de Recherche 8122, Centre National de la Recherche Scientifique, Institut Gustave Roussy, 39 Rue Camille Desmoulins, 94805 Villejuif Cedex, France Edited by John M. Coffin, Tufts University School of Medicine, Boston, MA, and approved August 19, 2003 (received for review May 2, 2003) Screening human sequence databases for endogenous retroviral plausible that some elements still possess functions of infectious elements with coding envelope genes has revealed 16 candidate retroviruses that may have been diverted by the host to its benefit. genes that we assayed for their fusogenic properties. All 16 genes Along this line, it has been proposed (reviewed in refs. 13 and 14) were cloned in a eukaryotic expression vector and assayed for that the HERV envelopes could play a role in several processes cell–cell fusion by using a large panel of mammalian cells in transient including (i) protection against infection by present-day retroviruses transfection assays. Fusion was observed for two human endogenous through receptor interference (15), (ii) protection of the fetus retrovirus (HERV) envelopes, the previously characterized HERV-W against the maternal immune system via an immunosuppressive envelope, also called syncytin, and a previously uncharacterized gene domain located in the envelope TM subunit (16, 17), and (iii) from the HERV-FRD family. Cells prone to env-mediated fusion were placenta morphogenesis through fusogenic effects, allowing differ- different for the two envelopes, indicating different receptor usage.
    [Show full text]
  • Structure and Dynamics of Influenza M2 Proton Channels from Solid-State NMR By
    Structure and Dynamics of Influenza M2 Proton Channels from Solid-State NMR by Venkata Shiva Mandala B.A. Biochemistry Oberlin College, 2015 Submitted to the Department of Chemistry in Partial Fulfillment of the Requirements for the Degree of DOCTOR OF PHILOSOPHY at the MASSACHUSETTS INSTITUTE OF TECHNOLOGY February 2021 ©2020 Massachusetts Institute of Technology. All rights reserved. Signature of Author _____________________________________________________________ Department of Chemistry September 28, 2020 Certified by ____________________________________________________________________ Mei Hong Professor of Chemistry Thesis Supervisor Accepted by ___________________________________________________________________ Adam P. Willard Associate Professor of Chemistry Graduate Officer This doctoral thesis has been examined by a committee of professors from the Department of Chemistry as follows: ______________________________________________________________________________ Matthew D. Shoulders Whitehead Career Development Associate Professor Thesis Committee Chair ______________________________________________________________________________ Mei Hong Professor of Chemistry Thesis Supervisor ______________________________________________________________________________ Robert G. Griffin Arthur Amos Noyes Professor of Chemistry Thesis Committee Member 2 Structure and Dynamics of Influenza M2 Proton Channels from Solid-State NMR by Venkata Shiva Mandala Submitted to the Department of Chemistry on October 9, 2020 in Partial Fulfillment of the
    [Show full text]
  • 160163 Data Sheet
    DATA SHEET Reagent: HIV-1 NL4-3 ΔEnv Vpr Luciferase Reporter Vector (pNL4-3.Luc.R-E-) Catalog Number: 3418 Lot Number: 160163 Release C Category: Provided: 5 μg of dried purified DNA stabilized in DNAstable PLUS Cloning Vector: pUC18 Ampicillin resistant Description: A HIV-1 NL4-3 luciferase reporter vector that contains defective Nef, Env and Vpr. Special This construct is 16,396 bp including the insert. Characteristics: In this reporter vector, a firefly luciferase gene was inserted into the pNL4-3 nef gene while frameshifts in env and vpr render this clone Env and Vpr deficient. To generate this plasmid, a frameshift near the 5'-end of env was introduced by using T4 DNA polymerase to fill in the NdeI site (nt 5950) of pNL4-3. This renders the clone Env deficient. A firefly luciferase gene was then inserted into the nef gene by removing the BamHI (nt 8021) to XhoI (nt 8443) fragment of pHXB-Luc (Chen et al. 1994) and ligating it to the same sites in env deficient pNL4-3. A frameshift was introduced in vpr by filling in the AflII site (nt 5180) corresponding to amino acid 26. This construct is competent for a single round of replication and requires co-transfection with an Env expression vector to produce infectious virus. Note: In this plasmid, Env was rendered deficient due to a small frameshift in the beginning of the Env gene. As a result, there is a possibility of recombinantion with another Env that could generate a viable virus. Please examine your sequences prior to generating pseudoviruses of any kind with this plasmid and exercise caution.
    [Show full text]